888.552.6760 SCHEDULE A CONSULTATION
MSOC

Funding cures

Gateway for Cancer Research funds transformational early-phase clinical trials for cancers of all types, bringing groundbreaking therapies to the bedside as quickly as possible for courageous patients facing cancer around the world. 

  • 99 cents of every dollar Gateway receives goes directly to fund phase I and phase II cancer trials, which are designed to determine whether new drugs or other treatments have the intended effect while also identifying the highest safe dose with the least amount of side effects.
  • Since 1991, Gateway has awarded more than $90 million in research grants, leading to new treatment options involving genomic profiling, precision medicine, stem cell therapy, immunotherapy and other advanced approaches.
  • Early-stage trials are some of the most underfunded, and many of the trials would not have proceeded with out Gateway support. The organization has enrolled over 9,000 cancer patients to take part in potentially life-saving new therapies.
"I see my husband healed. I see us getting old with more grandkids. I see no cancer in our future."

190+

Total Gateway-funded clinical trials

9,000

Patients currently enrolled

99

Of every dollar directly funds cancer clinical research

$16.56

Funds one patient for one day at a Gateway-funded clinical trial

"We are extremely grateful to the Gateway team for making this research possible. We clearly would not have been able to do this without their support."

DR. CHARALAMBOS ANDREADIS

Guidestar logo

By demonstrating a commitment to transparency, Gateway has achieved Platinum Participant status on Guidestar - a 501(c)3 charity that collects, organizes, and presents publically available information on nonprofit organizations.